Turtle Creek Wealth Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Turtle Creek Wealth Advisors's MRNA Position: Q2 2026 in Review
Turtle Creek Wealth Advisors opened a new position in Moderna (MRNA) in Q2 2026: 2,899 shares worth $203K. The stake represents 0.01% of the portfolio and ranks #448 among its holdings. This is a return to the name: Turtle Creek Wealth Advisors previously reported a position in MRNA as recently as Q4 2023.
Turtle Creek Wealth Advisors first reported a position in MRNA in Q4 2023 and has held it in 2 quarters since. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- Turtle Creek Wealth Advisors held 2,899 shares of Moderna worth $203K as of Q2 2026.
- Moderna was a new Turtle Creek Wealth Advisors position in Q2 2026.
- Moderna made up 0.01% of Turtle Creek Wealth Advisors's portfolio in Q2 2026, its #448 holding.
- Turtle Creek Wealth Advisors first reported a position in Moderna in Q4 2023 and has held it in 2 quarters since.
- 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on Turtle Creek Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.